At a glance
- Current status: Open
- Fund type: SEIS/EIS
- Investment goal: Capital growth
- Focus: UK SMEs, multi-sector
- Minimum portfolio size: 2
- Target returns: 2.5x
- Target holding period: 7 years
- Minimum subscription: £25,000
Cambridge VenturED is a new SEIS/EIS fund on a mission to invest in innovative companies at the early stages within the wider Cambridge entrepreneurial eco-system. The Fund's ambition is to find the most talented teams with ground-breaking ideas that have the potential to disrupt the status quo and ultimately create a paradigm shift. Cambridge VenturED provides an opportunity to invest in ideas that emerge into some of the world’s most exciting companies, gain exposure to Cambridge, and support early-stage potentially disruptive companies.
The Fund will invest in companies in sectors such as FinTech, Robotics, MedTech, Sustainability, BioTech, AI/ML, Crypto/Blockchain, Engineering, DeepTech, Healthcare, CleanTech and Environment, AgriTech, Life Sciences, etc.
SEIS & EIS tax incentives
The companies the fund invest in are expected to be SEIS-EIS-qualifying, which makes Cambridge VenturED Fund SEIS-EIS suitable for qualifying clients who would potentially benefit from the following tax reliefs:
- Up to 30% income tax relief (or 50% for SEIS)
- Tax-free investment growth
- Capital gains deferral (or 50% capital gains tax exemption for SEIS)
- Inheritance tax relief
- Loss relief
Please note: SEIS-EIS tax reliefs are only made available to investors because of the higher risks associated with investing in early-stage companies. Also, the availability of tax reliefs will depend on the investor's personal circumstances, and tax legislation can change in the future.
Fund team
- Dr. Ayla Selamoglu View bio
Example companies founded in the Cambridge ecosystem
Darktrace is a cybersecurity company leveraging AI techniques to better protect companies from advanced cyber attacks.
CMR Surgical is developing the next-generation surgical robotic system for minimal access surgery. CMR Surgical is to make minimal access surgery available to all.
GW Pharmaceuticals is a Cambridge based company that was founded over two decades ago to harness the medical benefits of marijuana and develop cannabis-based medicines.
.svg)